{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:09:37Z","timestamp":1768010977130,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ihj.2015.10.386","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T09:08:15Z","timestamp":1448442495000},"page":"S61-S68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Decongestion: Diuretics and other therapies for hospitalized heart failure"],"prefix":"10.1016","volume":"68","author":[{"given":"Ali","family":"Vazir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2015.10.386_bib0255","series-title":"Improving care for patients with acute heart failure before, during and after hospitalization","author":"Cowie","year":"2014"},{"key":"10.1016\/j.ihj.2015.10.386_bib0260","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0265","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0275","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0280","series-title":"Acute heart failure: diagnosing and managing acute heart failure in adults. NICE guideline (CG187)","year":"2014"},{"key":"10.1016\/j.ihj.2015.10.386_bib0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4236\/wjcd.2013.32A004","article-title":"The use of diuretics in acute heart failure: evidence based therapy?","volume":"03","author":"Vazir","year":"2013","journal-title":"World J Cardiovasc Dis"},{"key":"10.1016\/j.ihj.2015.10.386_bib0295","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.10.386_bib0300","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/j.1552-4604.1982.tb02644.x","article-title":"Slow-release furosemide and hydrochlorothiazide in congestive cardiac failure: a controlled trial","volume":"22","author":"Vermeulen","year":"1982","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.4.5834.196","article-title":"High dosage metolazone in chronic renal failure","volume":"4","author":"Dargie","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1185\/03007998409109571","article-title":"Frusemide\/amiloride combination (\u2018Frumil\u2019) in heart failure: an open, multi-centre study in general practice","volume":"9","author":"Townsend","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ihj.2015.10.386_bib0320","first-page":"273","article-title":"Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene","volume":"26","author":"Kohvakka","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0325","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1185\/03007997609111998","article-title":"Bumetanide in congestive heart failure","volume":"4","author":"Kourouklis","year":"1976","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ihj.2015.10.386_bib0330","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1875-9114.1994.tb02848.x","article-title":"Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group","volume":"14","author":"Patterson","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ihj.2015.10.386_bib0335","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5473.1277","article-title":"Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid","volume":"2","author":"Stewart","year":"1965","journal-title":"Br Med J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/030006058801600209","article-title":"A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice","volume":"16","author":"Crawford","year":"1988","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ihj.2015.10.386_bib0350","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1055\/s-2008-1069093","article-title":"[Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene]","volume":"110","author":"Gonska","year":"1985","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ihj.2015.10.386_bib0355","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00541540","article-title":"Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure","volume":"30","author":"Funke Kupper","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0360","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.10.386_bib0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ihj.2015.10.386_bib0370","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semnephrol.2011.09.006","article-title":"Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites","volume":"31","author":"Tuttolomondo","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0375","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1527-5299.2002.0758.x","article-title":"Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure","volume":"8","author":"Ravnan","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ki.1984.153","article-title":"Bumetanide and furosemide in heart failure","volume":"26","author":"Brater","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.ihj.2015.10.386_bib0390","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2015.10.386_bib0395","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","article-title":"Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0400","first-page":"F1269","article-title":"Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport","volume":"255","author":"Stanton","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0405","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","article-title":"Metolazone in treatment of severe refractory congestive cardiac failure","volume":"335","author":"Kiyingi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.10.386_bib0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(75)90041-1","article-title":"The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide","volume":"89","author":"Sigurd","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2015.10.386_bib0415","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.10.386_bib0420","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.107.737106","article-title":"Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action","volume":"117","author":"Elkayam","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.10.386_bib0425","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","article-title":"Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial","volume":"172","author":"Triposkiadis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0430","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ihj.2015.10.386_bib0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jcaf.2003.28","article-title":"Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients","volume":"9","author":"Jaski","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0440","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0445","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ndt\/gfg590","article-title":"Continuous haematocrit monitoring during intradialytic hypotension: precipitous decline in plasma refill rates","volume":"19","author":"Schroeder","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ihj.2015.10.386_bib0450","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0735-1097(01)01479-6","article-title":"Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure","volume":"38","author":"Marenzi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0455","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.10.386_bib0460","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ihj.2015.10.386_bib0465","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ihj.2015.10.386_bib0470","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.10.386_bib0475","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0828-282X(07)70840-1","article-title":"Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance","volume":"23","author":"Liu","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0480","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/jpet.111.184796","article-title":"Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure","volume":"339","author":"Liu","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ihj.2015.10.386_bib0485","doi-asserted-by":"crossref","first-page":"517.e5","DOI":"10.1016\/j.ajem.2011.01.023","article-title":"The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?","volume":"30","author":"Massari","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ihj.2015.10.386_bib0490","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/FJC.0000000000000048","article-title":"Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study","volume":"63","author":"Liu","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ihj.2015.10.386_bib0495","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ihj.2015.10.386_bib0500","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.170","article-title":"Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome \u2013 an analysis from RELAX-AHF","volume":"16","author":"Voors","year":"2014","journal-title":"Eur J Heart Fail"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215008317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215008317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:36:43Z","timestamp":1718213803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483215008317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":50,"alternative-id":["S0019483215008317"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2015.10.386","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decongestion: Diuretics and other therapies for hospitalized heart failure","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2015.10.386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}